France-based medical research technology provider Owkin increased a series A round featuring GV, a corporate venture capital subsidiary of internet and technology group Alphabet, to $70m yesterday.
Development bank BPIfrance’s Large Venture fund joined Abu Dhabi sovereign wealth fund Mubadala Capital to invest $18m. The company has now raised a total of $72m since it was founded in 2016.
Owkin has built an online platform that enables pharmaceutical companies, clinicians, data scientists and academic researchers to collaborate with each other and use artificial intelligence to create large-scale distributed data models.
The round stood at $15.9m as of a $4.9m investment by GV in mid-2018 that followed funding from Otium Venture, Cathay Innovation, Plug and Play and NJF Capital earlier the same year.
GV joined investment and financial services group Fidelity’s Eight Road Ventures and F-Prime Capital units, Cathay Capital and NJF Capital to add an undisclosed amount in March 2019, before the first four took part in a $25m close with MACSF in May this year.
